{"pub_date": "2016-04-27T00:00:00Z", "subsection_name": null, "lead_paragraph": "The burden of drug pricing often falls most heavily on the uninsured, who must pay list price.", "print_page": "1", "document_type": "article", "byline": {"person": [{"rank": 1, "organization": "", "lastname": "THOMAS", "firstname": "Katie", "role": "reported"}], "original": "By KATIE THOMAS"}, "multimedia": [{"width": 190, "height": 126, "url": "images/2016/04/27/business/27drugprices/27drugprices-thumbWide.jpg", "subtype": "wide", "legacy": {"wide": "images/2016/04/27/business/27drugprices/27drugprices-thumbWide.jpg", "widewidth": "190", "wideheight": "126"}, "type": "image"}, {"width": 600, "height": 400, "url": "images/2016/04/27/business/27drugprices/27drugprices-articleLarge.jpg", "subtype": "xlarge", "legacy": {"xlargewidth": "600", "xlargeheight": "400", "xlarge": "images/2016/04/27/business/27drugprices/27drugprices-articleLarge.jpg"}, "type": "image"}, {"width": 75, "height": 75, "url": "images/2016/04/27/business/27drugprices/27drugprices-thumbStandard.jpg", "subtype": "thumbnail", "legacy": {"thumbnail": "images/2016/04/27/business/27drugprices/27drugprices-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "type": "image"}], "section_name": "Business Day", "headline": {"print_headline": "Under Fire Over Prices, Drug Makers Keep Raising Them", "main": "Drug Prices Keep Rising Despite Intense Criticism"}, "source": "The New York Times", "blog": [], "word_count": "1044", "web_url": "http://www.nytimes.com/2016/04/27/business/drug-prices-keep-rising-despite-intense-criticism.html", "slideshow_credits": null, "news_desk": "Business", "type_of_material": "News", "snippet": "The burden of drug pricing often falls most heavily on the uninsured, who must pay list price.", "_id": "571fb11438f0d80819781b2e", "abstract": "Drug makers including Johnson & Johnson have raised prices on brand-name drugs by double-digit percentages in 2016; drug prices rose more than 12 percent in 2015; increases come despite strong criticism, including fact that biggest burden falls on uninsured patients.", "keywords": [{"rank": "1", "name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "Y"}, {"rank": "2", "name": "organizations", "value": "Johnson & Johnson", "is_major": "Y"}, {"rank": "3", "name": "subject", "value": "Health Insurance and Managed Care", "is_major": "Y"}, {"rank": "4", "name": "persons", "value": "Pearson, John Michael (1959- )", "is_major": "N"}, {"rank": "5", "name": "organizations", "value": "IMS Health", "is_major": "N"}, {"rank": "6", "name": "subject", "value": "Discount Selling", "is_major": "N"}, {"rank": "7", "name": "subject", "value": "Research", "is_major": "N"}, {"rank": "8", "name": "organizations", "value": "Valeant Pharmaceuticals International Inc", "is_major": "N"}]}